(Q73206602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Breast cancer screening (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

B E Sirovich

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H C Sox

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

Surgical Clinics of North America

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

961-990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

The relation between survival and age at diagnosis in breast cancer

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The promise and problems of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Mammography versus clinical examination of the breasts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Benefits and risks of screening mammography for women in their forties: a statistical appraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Screening for disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The price of mammography in the United States: data from the National Survey of Mammography Facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

In search of the best upper age limit for breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Effect of breast cancer screening after age 65

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Roles of mammography in the early detection of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Ten-year risk of false positive screening mammograms and clinical breast examinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Mammography screening for women aged 40 through 49--a guidelines saga and a clarion call for informed decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Clinical efficacy of mammographic screening in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Radiation risk from screening mammography of women aged 40-49 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Report of the International Workshop on Screening for Breast Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Clinical breast examination and breast self-examination. Past and present effect on breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Variation of benefits and harms of breast cancer screening with age

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

American and European recommendations for screening mammography in younger women: a cultural divide?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Effect of age, breast density, and family history on the sensitivity of first screening mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Controversies in screening with mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Screening mammography in young women: a different perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Canadian National Breast Screening Study: update on breast cancer mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast cancer: age-specific growth rates and screening strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast self-examination in relation to the occurrence of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast cancer screening with mammography: overview of Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Study design of randomized controlled clinical trials of breast cancer screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Contentious screening decisions: does the choice matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Age-dependent growth rate of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Concepts and problems in the evaluation of screening programs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Edinburgh trial of screening for breast cancer: mortality at seven years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The clinical significance of pre-invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The role of numeracy in understanding the benefit of screening mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Evidence on screening for breast cancer from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Periodic breast cancer screening in seven foreign countries

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Benefit and harm associated with screening for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Survey mammography as a case finding method for routine and postmastectomized patients.A 5-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Randomized trial of breast self-examination in Shanghai: methodology and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Estimating treatment benefits for the elderly: the effect of competing risks

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Diagnostic testing following screening mammography in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

The Edinburgh Randomized Trial of Breast Cancer Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970056-6

7 January 2021

10.1016/S0039-6109(05)70056-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference